Search Results 461-470 of 16393 for anti-TNF drugs

  1. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

  2. Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer - Mayo Clinic

    Radiation therapy, such as stereotactic body radiation therapy ... agents, corticosteroids or immunosuppressive drugs). ... anti-retroviral therapy, has had at ...

  3. Ocrelizumab (intravenous route) - Side effects & uses - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  4. An Open-label Study to Assess the Anti-Tumor Activity and Safety of REGN1979, an Anti-CD20 X Anti-CD3 Bispecific Antibody, in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    Prior treatment with an anti-CD20 x anti-CD3 bispecific therapy. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last ...

  5. painkillers Archives - Mayo Clinic News Network

    ... anti-inflammatory drugs (NSAIDs) is associated with a significant risk of acute myocardial infarction. Mayo Clinic cardiologist Dr. Stephen Kopecky, […] The ...

  6. Melanoma Clinical Trials

    ... anti-PD-[L]-1 therapy. A Study of the Effectiveness of Stress Management Therapy for Patients with Melanoma Rochester, MN. The purpose of this study is to ...

  7. Cancer Clinical Trials - Medical Professionals

    A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...

  8. A Study to Assess the Effectiveness and Safety of Apremilast in Pediatric Patients (6 through 17 years old) with Moderate-to-Severe Plaque Psoriasis - Mayo Clinic

    Etanercept (or biosimilar) treatment four weeks prior to randomization;; Adalimumab (or biosimilar) treatment ten weeks prior to randomization;; Other TNF or ...

  9. Two Drugs Do Not Improve Kidney Function in Acute Heart Failure Patients - Mayo Clinic News Network

    Compared to placebo, researchers found that neither dopamine nor nesiritide, when also used with diuretic (water pills) therapy, was better at increasing urine ...

  10. Science Saturday: Genetic testing for earlier diagnosis and treatment of rheumatoid arthritis - Mayo Clinic News Network

    ... therapy, especially newly developed biological agents. The authors also provide suggested clinical guidelines for using genetic testing to guide treatment ...